ClearPoint Neuro Inc. (CLPT) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Greetings and welcome to the ClearPoint Neuro, Inc. First Quarter 2026 Financial Results. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. Comments made on this call may include statements that are forward-looking within the meaning of securities laws. These forward-looking statements may include, without limitation, statements related to anticipated industry trends, the company's plans, prospects and strategies, both preliminary and projected. The size of total addressable markets or the market opportunity for the company's products and services. The company's expectations regarding the integration, performance, and anticipated benefits of its recent acquisition of ERAS Holdings Inc., including operational efficiencies and the impact on the company's financial condition and results of operations. the company's expectation for future development, regulatory approval, timing, commercialization, and the market for cell and gene therapies, and the anticipated adoption of the company's products and services for use in the delivery of gene and cell therapies, and management's expectations, beliefs, estimates, or projections regarding future revenue and results of operations. You are cautioned not to place undue reliance on forward-looking statements which speak only as of the date on which they were made. Actual results or trends could differ materially. The company undertakes no obligation to revise forward-looking statements for new information or future events. For more information about the company's risks and uncertainties, please refer to the compan...